Additionally, Willin/FRMD6 plays an important role in regulating Hippo, ERK, and mTOR signaling pathways, which are involved in various features of AD pathology including impairment of the blood–brain barrier, oxidative stress, microglia activation, and inflammation. Here, MTOR is linked to Alzheimer disease.